Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study (Q46542857)
Jump to navigation
Jump to search
scientific article published on 10 June 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study |
scientific article published on 10 June 2008 |
Statements
1 reference
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study (English)
1 reference
1 reference
M L Rothenberg
1 reference
J V Cox
1 reference
C Butts
1 reference
M Navarro
1 reference
Y-J Bang
1 reference
R Goel
1 reference
S Gollins
1 reference
L L Siu
1 reference
S Laguerre
1 reference
10 June 2008
1 reference
1 reference
19
1 reference
10
1 reference
1720-1726
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference